Zicam: Homeopathy Fails the Sniff Test

By Terry J. Allen

The Food and Drug Administration (FDA) has caught itself in a trap of precedent and logic that should force it, finally, to regulate homeopathic products. FDA regulations require that drugs and treatments be "scientifically proven safe and effective." Homeopathic remedies, except when people rely on [RETURN TO ARTICLE]

  • Reader Comments

     Page 1 of 1 pages

    “shaking and serial dilutions

    Singapore Posted by Calvin Loh on Jul 15, 2009 at 9:21 AM

    Calvin,

    I’m genuinely curious, how many commercially available medicines can’t be shown to have a statistically significant effect above placebo? This isn’t a trick question, I don’t know the answer.

    United Kingdom Posted by tom shuttleworth on Jul 16, 2009 at 2:53 PM

    Do you own Matrixx stock (Nasdaq - MTXX)?

    I work with a law firm investigating reports of possible securities law violations by Matrixx Initiatives, Inc., the maker of Zicam.

    In a letter to Matrixx, the FDA concluded certain Zicam products may pose serious risks to consumers.

    When the letter was released, Matrixx stock plummeted from approximately $19 per share to less than $7 per share. Since December 2007, insiders have sold more than $2.7 million worth of Matrixx shares.

    Learn more: www.hbsslaw.com/matrixx

    United States Posted by HBSS on Jul 22, 2009 at 1:22 PM
     Page 1 of 1 pages

  • register a new account »Posting Security

    To participate in our forums, please register for a free account.
     

    Retreive lost password »